臨床研究サービス(CRS) - 世界市場シェアとランキング、全体売上高と需要予測 2024-2030Clinical Research Services (CRS) - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030 この臨床研究サービス調達調査レポートは、重要なコスト要因と現在の供給市場動向の予測分析を提供し、コストの観点から市場の理解を促進します。 慢性疾患の相殺、高齢化人口の増加、支出の可能性の増大は、新... もっと見る
※当ページの内容はウェブ更新時の情報です。
サマリーこの臨床研究サービス調達調査レポートは、重要なコスト要因と現在の供給市場動向の予測分析を提供し、コストの観点から市場の理解を促進します。慢性疾患の相殺、高齢化人口の増加、支出の可能性の増大は、新薬や治療法の開発に道を開いています。その結果、製薬業界は新薬開発のために様々な臨床研究サービスの採用を増やしており、一方、医療業界は治療費をより安価にするためのサービスを求めている。 臨床研究サービス(CRS)の世界市場は、2023年に100万米ドル規模と推定され、2024年から2030年の予測期間中に年平均成長率(CAGR)%で2030年までに100万米ドルに再調整されると予測されています。 臨床研究サービス(CRS)の北米市場は、2023年に百万ドルと評価され、2024年から2030年の予測期間中に%のCAGRで、2030年までに百万ドルに達すると予測しています。 臨床研究サービス(CRS)のアジア太平洋市場は、2023年に100万ドルと評価され、2024年から2030年の予測期間中に%のCAGRで、2030年までに100万ドルに達するだろう。 臨床研究サービス(CRS)のヨーロッパ市場は、2023年に100万ドルと評価され、2024年から2030年の予測期間中に%のCAGRで、2030年までに100万ドルに達するでしょう。 臨床研究サービス(CRS)の世界の主要企業には、Labcorp、IQVIA、Syneos Health、Parexel、PRA、PPD、CRL、ICONなどが含まれます。2023年には、世界の大手5社が売上高で約 %のシェアを占めている。 レポートの範囲 本レポートは、臨床研究サービス(CRS)の世界市場について、地域別・国別、タイプ別、用途別の分析とともに、総売上高、主要企業の市場シェア、ランキングを中心に包括的に紹介することを目的としています。 臨床研究サービス(CRS)の市場規模、推計、予測は、2023年を基準年とし、2019年から2030年までの期間の履歴データと予測データを売上高(百万ドル)で提供しています。定量的および定性的な分析により、読者がビジネス/成長戦略を策定し、市場競争状況を評価し、現在の市場における自社のポジションを分析し、臨床研究サービス(CRS)に関する情報に基づいたビジネス上の意思決定を行うのに役立ちます。 市場区分 企業別 ラボコープ IQVIA シネオスヘルス パレクセル PRA PPD CRL アイコン タイプ別セグメント 初期段階サービス 後期サービス その他のサービス アプリケーション別セグメント がん 心血管 中枢神経系 感染症 代謝性疾患 その他の疾患 地域別 北米 米国 カナダ 欧州 ドイツ フランス イギリス イタリア ロシア アジア太平洋 中国 日本 韓国 中国 台湾 東南アジア インド ラテンアメリカ メキシコ ブラジル アルゼンチン 中東・アフリカ トルコ サウジアラビア アラブ首長国連邦 各章の概要 第1章:報告書のスコープ、世界の総市場規模を紹介します。本章では、市場ダイナミクス、市場の最新動向、市場の推進要因と制限要因、業界メーカーが直面する課題とリスク、業界の関連政策の分析も提供します。 第2章:臨床研究サービス(CRS)メーカーの競争環境、収益市場シェア、最新の開発計画、合併・買収情報などを詳細に分析。 第3章:タイプ別に様々な市場セグメントの分析を提供し、各市場セグメントの市場規模と発展可能性を網羅し、読者が異なる市場セグメントでブルーオーシャン市場を見つけるのに役立ちます。 第4章:読者が異なる川下市場におけるブルーオーシャン市場を見つけるのを助けるために、各市場セグメントの市場規模と発展の可能性をカバーする、アプリケーション別に様々な市場セグメントの分析を提供します。 第5章:地域レベルでの臨床研究サービス(CRS)の収益。各地域の市場規模と発展可能性を定量的に分析し、世界各国の市場発展、今後の発展見通し、市場スペース、市場規模を紹介しています。 第6章 臨床研究サービス(CRS)の国別収益。各国/地域のタイプ別、用途別のシグメイトデータを掲載しています。 第7章:主要企業のプロファイルを提供し、製品収益、売上総利益率、製品紹介、最近の開発など、市場における主要企業の基本的な状況を詳細に紹介する。 第8章:産業の上流と下流を含む産業チェーンの分析。 第9章:結論 目次1 Market Overview1.1 Clinical Research Services (CRS) Product Introduction 1.2 Global Clinical Research Services (CRS) Market Size Forecast 1.3 Clinical Research Services (CRS) Market Trends & Drivers 1.3.1 Clinical Research Services (CRS) Industry Trends 1.3.2 Clinical Research Services (CRS) Market Drivers & Opportunity 1.3.3 Clinical Research Services (CRS) Market Challenges 1.3.4 Clinical Research Services (CRS) Market Restraints 1.4 Assumptions and Limitations 1.5 Study Objectives 1.6 Years Considered 2 Competitive Analysis by Company 2.1 Global Clinical Research Services (CRS) Players Revenue Ranking (2023) 2.2 Global Clinical Research Services (CRS) Revenue by Company (2019-2024) 2.3 Key Companies Clinical Research Services (CRS) Manufacturing Base Distribution and Headquarters 2.4 Key Companies Clinical Research Services (CRS) Product Offered 2.5 Key Companies Time to Begin Mass Production of Clinical Research Services (CRS) 2.6 Clinical Research Services (CRS) Market Competitive Analysis 2.6.1 Clinical Research Services (CRS) Market Concentration Rate (2019-2024) 2.6.2 Global 5 and 10 Largest Companies by Clinical Research Services (CRS) Revenue in 2023 2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Clinical Research Services (CRS) as of 2023) 2.7 Mergers & Acquisitions, Expansion 3 Segmentation by Type 3.1 Introduction by Type 3.1.1 Early Phase Services 3.1.2 Late Phase Services 3.1.3 Other Services 3.2 Global Clinical Research Services (CRS) Sales Value by Type 3.2.1 Global Clinical Research Services (CRS) Sales Value by Type (2019 VS 2023 VS 2030) 3.2.2 Global Clinical Research Services (CRS) Sales Value, by Type (2019-2030) 3.2.3 Global Clinical Research Services (CRS) Sales Value, by Type (%) (2019-2030) 4 Segmentation by Application 4.1 Introduction by Application 4.1.1 Cancer 4.1.2 Cardiovascular 4.1.3 CNS 4.1.4 Infectious Diseases 4.1.5 Metabolic Diseases 4.1.6 Other Diseases 4.2 Global Clinical Research Services (CRS) Sales Value by Application 4.2.1 Global Clinical Research Services (CRS) Sales Value by Application (2019 VS 2023 VS 2030) 4.2.2 Global Clinical Research Services (CRS) Sales Value, by Application (2019-2030) 4.2.3 Global Clinical Research Services (CRS) Sales Value, by Application (%) (2019-2030) 5 Segmentation by Region 5.1 Global Clinical Research Services (CRS) Sales Value by Region 5.1.1 Global Clinical Research Services (CRS) Sales Value by Region: 2019 VS 2023 VS 2030 5.1.2 Global Clinical Research Services (CRS) Sales Value by Region (2019-2024) 5.1.3 Global Clinical Research Services (CRS) Sales Value by Region (2025-2030) 5.1.4 Global Clinical Research Services (CRS) Sales Value by Region (%), (2019-2030) 5.2 North America 5.2.1 North America Clinical Research Services (CRS) Sales Value, 2019-2030 5.2.2 North America Clinical Research Services (CRS) Sales Value by Country (%), 2023 VS 2030 5.3 Europe 5.3.1 Europe Clinical Research Services (CRS) Sales Value, 2019-2030 5.3.2 Europe Clinical Research Services (CRS) Sales Value by Country (%), 2023 VS 2030 5.4 Asia Pacific 5.4.1 Asia Pacific Clinical Research Services (CRS) Sales Value, 2019-2030 5.4.2 Asia Pacific Clinical Research Services (CRS) Sales Value by Country (%), 2023 VS 2030 5.5 South America 5.5.1 South America Clinical Research Services (CRS) Sales Value, 2019-2030 5.5.2 South America Clinical Research Services (CRS) Sales Value by Country (%), 2023 VS 2030 5.6 Middle East & Africa 5.6.1 Middle East & Africa Clinical Research Services (CRS) Sales Value, 2019-2030 5.6.2 Middle East & Africa Clinical Research Services (CRS) Sales Value by Country (%), 2023 VS 2030 6 Segmentation by Key Countries/Regions 6.1 Key Countries/Regions Clinical Research Services (CRS) Sales Value Growth Trends, 2019 VS 2023 VS 2030 6.2 Key Countries/Regions Clinical Research Services (CRS) Sales Value 6.3 United States 6.3.1 United States Clinical Research Services (CRS) Sales Value, 2019-2030 6.3.2 United States Clinical Research Services (CRS) Sales Value by Type (%), 2023 VS 2030 6.3.3 United States Clinical Research Services (CRS) Sales Value by Application, 2023 VS 2030 6.4 Europe 6.4.1 Europe Clinical Research Services (CRS) Sales Value, 2019-2030 6.4.2 Europe Clinical Research Services (CRS) Sales Value by Type (%), 2023 VS 2030 6.4.3 Europe Clinical Research Services (CRS) Sales Value by Application, 2023 VS 2030 6.5 China 6.5.1 China Clinical Research Services (CRS) Sales Value, 2019-2030 6.5.2 China Clinical Research Services (CRS) Sales Value by Type (%), 2023 VS 2030 6.5.3 China Clinical Research Services (CRS) Sales Value by Application, 2023 VS 2030 6.6 Japan 6.6.1 Japan Clinical Research Services (CRS) Sales Value, 2019-2030 6.6.2 Japan Clinical Research Services (CRS) Sales Value by Type (%), 2023 VS 2030 6.6.3 Japan Clinical Research Services (CRS) Sales Value by Application, 2023 VS 2030 6.7 South Korea 6.7.1 South Korea Clinical Research Services (CRS) Sales Value, 2019-2030 6.7.2 South Korea Clinical Research Services (CRS) Sales Value by Type (%), 2023 VS 2030 6.7.3 South Korea Clinical Research Services (CRS) Sales Value by Application, 2023 VS 2030 6.8 Southeast Asia 6.8.1 Southeast Asia Clinical Research Services (CRS) Sales Value, 2019-2030 6.8.2 Southeast Asia Clinical Research Services (CRS) Sales Value by Type (%), 2023 VS 2030 6.8.3 Southeast Asia Clinical Research Services (CRS) Sales Value by Application, 2023 VS 2030 6.9 India 6.9.1 India Clinical Research Services (CRS) Sales Value, 2019-2030 6.9.2 India Clinical Research Services (CRS) Sales Value by Type (%), 2023 VS 2030 6.9.3 India Clinical Research Services (CRS) Sales Value by Application, 2023 VS 2030 7 Company Profiles 7.1 Labcorp 7.1.1 Labcorp Profile 7.1.2 Labcorp Main Business 7.1.3 Labcorp Clinical Research Services (CRS) Products, Services and Solutions 7.1.4 Labcorp Clinical Research Services (CRS) Revenue (US$ Million) & (2019-2024) 7.1.5 Labcorp Recent Developments 7.2 IQVIA 7.2.1 IQVIA Profile 7.2.2 IQVIA Main Business 7.2.3 IQVIA Clinical Research Services (CRS) Products, Services and Solutions 7.2.4 IQVIA Clinical Research Services (CRS) Revenue (US$ Million) & (2019-2024) 7.2.5 IQVIA Recent Developments 7.3 Syneos Health 7.3.1 Syneos Health Profile 7.3.2 Syneos Health Main Business 7.3.3 Syneos Health Clinical Research Services (CRS) Products, Services and Solutions 7.3.4 Syneos Health Clinical Research Services (CRS) Revenue (US$ Million) & (2019-2024) 7.3.5 Parexel Recent Developments 7.4 Parexel 7.4.1 Parexel Profile 7.4.2 Parexel Main Business 7.4.3 Parexel Clinical Research Services (CRS) Products, Services and Solutions 7.4.4 Parexel Clinical Research Services (CRS) Revenue (US$ Million) & (2019-2024) 7.4.5 Parexel Recent Developments 7.5 PRA 7.5.1 PRA Profile 7.5.2 PRA Main Business 7.5.3 PRA Clinical Research Services (CRS) Products, Services and Solutions 7.5.4 PRA Clinical Research Services (CRS) Revenue (US$ Million) & (2019-2024) 7.5.5 PRA Recent Developments 7.6 PPD 7.6.1 PPD Profile 7.6.2 PPD Main Business 7.6.3 PPD Clinical Research Services (CRS) Products, Services and Solutions 7.6.4 PPD Clinical Research Services (CRS) Revenue (US$ Million) & (2019-2024) 7.6.5 PPD Recent Developments 7.7 CRL 7.7.1 CRL Profile 7.7.2 CRL Main Business 7.7.3 CRL Clinical Research Services (CRS) Products, Services and Solutions 7.7.4 CRL Clinical Research Services (CRS) Revenue (US$ Million) & (2019-2024) 7.7.5 CRL Recent Developments 7.8 ICON 7.8.1 ICON Profile 7.8.2 ICON Main Business 7.8.3 ICON Clinical Research Services (CRS) Products, Services and Solutions 7.8.4 ICON Clinical Research Services (CRS) Revenue (US$ Million) & (2019-2024) 7.8.5 ICON Recent Developments 8 Industry Chain Analysis 8.1 Clinical Research Services (CRS) Industrial Chain 8.2 Clinical Research Services (CRS) Upstream Analysis 8.2.1 Key Raw Materials 8.2.2 Raw Materials Key Suppliers 8.2.3 Manufacturing Cost Structure 8.3 Midstream Analysis 8.4 Downstream Analysis (Customers Analysis) 8.5 Sales Model and Sales Channels 8.5.1 Clinical Research Services (CRS) Sales Model 8.5.2 Sales Channel 8.5.3 Clinical Research Services (CRS) Distributors 9 Research Findings and Conclusion 10 Appendix 10.1 Research Methodology 10.1.1 Methodology/Research Approach 10.1.2 Data Source 10.2 Author Details 10.3 Disclaimer
SummaryThis clinical research services procurement research report offers a predictive analysis of the critical cost drivers and the current supply market trends that will facilitate a better understanding of the market from the cost perspective. Table of Contents1 Market Overview1.1 Clinical Research Services (CRS) Product Introduction 1.2 Global Clinical Research Services (CRS) Market Size Forecast 1.3 Clinical Research Services (CRS) Market Trends & Drivers 1.3.1 Clinical Research Services (CRS) Industry Trends 1.3.2 Clinical Research Services (CRS) Market Drivers & Opportunity 1.3.3 Clinical Research Services (CRS) Market Challenges 1.3.4 Clinical Research Services (CRS) Market Restraints 1.4 Assumptions and Limitations 1.5 Study Objectives 1.6 Years Considered 2 Competitive Analysis by Company 2.1 Global Clinical Research Services (CRS) Players Revenue Ranking (2023) 2.2 Global Clinical Research Services (CRS) Revenue by Company (2019-2024) 2.3 Key Companies Clinical Research Services (CRS) Manufacturing Base Distribution and Headquarters 2.4 Key Companies Clinical Research Services (CRS) Product Offered 2.5 Key Companies Time to Begin Mass Production of Clinical Research Services (CRS) 2.6 Clinical Research Services (CRS) Market Competitive Analysis 2.6.1 Clinical Research Services (CRS) Market Concentration Rate (2019-2024) 2.6.2 Global 5 and 10 Largest Companies by Clinical Research Services (CRS) Revenue in 2023 2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Clinical Research Services (CRS) as of 2023) 2.7 Mergers & Acquisitions, Expansion 3 Segmentation by Type 3.1 Introduction by Type 3.1.1 Early Phase Services 3.1.2 Late Phase Services 3.1.3 Other Services 3.2 Global Clinical Research Services (CRS) Sales Value by Type 3.2.1 Global Clinical Research Services (CRS) Sales Value by Type (2019 VS 2023 VS 2030) 3.2.2 Global Clinical Research Services (CRS) Sales Value, by Type (2019-2030) 3.2.3 Global Clinical Research Services (CRS) Sales Value, by Type (%) (2019-2030) 4 Segmentation by Application 4.1 Introduction by Application 4.1.1 Cancer 4.1.2 Cardiovascular 4.1.3 CNS 4.1.4 Infectious Diseases 4.1.5 Metabolic Diseases 4.1.6 Other Diseases 4.2 Global Clinical Research Services (CRS) Sales Value by Application 4.2.1 Global Clinical Research Services (CRS) Sales Value by Application (2019 VS 2023 VS 2030) 4.2.2 Global Clinical Research Services (CRS) Sales Value, by Application (2019-2030) 4.2.3 Global Clinical Research Services (CRS) Sales Value, by Application (%) (2019-2030) 5 Segmentation by Region 5.1 Global Clinical Research Services (CRS) Sales Value by Region 5.1.1 Global Clinical Research Services (CRS) Sales Value by Region: 2019 VS 2023 VS 2030 5.1.2 Global Clinical Research Services (CRS) Sales Value by Region (2019-2024) 5.1.3 Global Clinical Research Services (CRS) Sales Value by Region (2025-2030) 5.1.4 Global Clinical Research Services (CRS) Sales Value by Region (%), (2019-2030) 5.2 North America 5.2.1 North America Clinical Research Services (CRS) Sales Value, 2019-2030 5.2.2 North America Clinical Research Services (CRS) Sales Value by Country (%), 2023 VS 2030 5.3 Europe 5.3.1 Europe Clinical Research Services (CRS) Sales Value, 2019-2030 5.3.2 Europe Clinical Research Services (CRS) Sales Value by Country (%), 2023 VS 2030 5.4 Asia Pacific 5.4.1 Asia Pacific Clinical Research Services (CRS) Sales Value, 2019-2030 5.4.2 Asia Pacific Clinical Research Services (CRS) Sales Value by Country (%), 2023 VS 2030 5.5 South America 5.5.1 South America Clinical Research Services (CRS) Sales Value, 2019-2030 5.5.2 South America Clinical Research Services (CRS) Sales Value by Country (%), 2023 VS 2030 5.6 Middle East & Africa 5.6.1 Middle East & Africa Clinical Research Services (CRS) Sales Value, 2019-2030 5.6.2 Middle East & Africa Clinical Research Services (CRS) Sales Value by Country (%), 2023 VS 2030 6 Segmentation by Key Countries/Regions 6.1 Key Countries/Regions Clinical Research Services (CRS) Sales Value Growth Trends, 2019 VS 2023 VS 2030 6.2 Key Countries/Regions Clinical Research Services (CRS) Sales Value 6.3 United States 6.3.1 United States Clinical Research Services (CRS) Sales Value, 2019-2030 6.3.2 United States Clinical Research Services (CRS) Sales Value by Type (%), 2023 VS 2030 6.3.3 United States Clinical Research Services (CRS) Sales Value by Application, 2023 VS 2030 6.4 Europe 6.4.1 Europe Clinical Research Services (CRS) Sales Value, 2019-2030 6.4.2 Europe Clinical Research Services (CRS) Sales Value by Type (%), 2023 VS 2030 6.4.3 Europe Clinical Research Services (CRS) Sales Value by Application, 2023 VS 2030 6.5 China 6.5.1 China Clinical Research Services (CRS) Sales Value, 2019-2030 6.5.2 China Clinical Research Services (CRS) Sales Value by Type (%), 2023 VS 2030 6.5.3 China Clinical Research Services (CRS) Sales Value by Application, 2023 VS 2030 6.6 Japan 6.6.1 Japan Clinical Research Services (CRS) Sales Value, 2019-2030 6.6.2 Japan Clinical Research Services (CRS) Sales Value by Type (%), 2023 VS 2030 6.6.3 Japan Clinical Research Services (CRS) Sales Value by Application, 2023 VS 2030 6.7 South Korea 6.7.1 South Korea Clinical Research Services (CRS) Sales Value, 2019-2030 6.7.2 South Korea Clinical Research Services (CRS) Sales Value by Type (%), 2023 VS 2030 6.7.3 South Korea Clinical Research Services (CRS) Sales Value by Application, 2023 VS 2030 6.8 Southeast Asia 6.8.1 Southeast Asia Clinical Research Services (CRS) Sales Value, 2019-2030 6.8.2 Southeast Asia Clinical Research Services (CRS) Sales Value by Type (%), 2023 VS 2030 6.8.3 Southeast Asia Clinical Research Services (CRS) Sales Value by Application, 2023 VS 2030 6.9 India 6.9.1 India Clinical Research Services (CRS) Sales Value, 2019-2030 6.9.2 India Clinical Research Services (CRS) Sales Value by Type (%), 2023 VS 2030 6.9.3 India Clinical Research Services (CRS) Sales Value by Application, 2023 VS 2030 7 Company Profiles 7.1 Labcorp 7.1.1 Labcorp Profile 7.1.2 Labcorp Main Business 7.1.3 Labcorp Clinical Research Services (CRS) Products, Services and Solutions 7.1.4 Labcorp Clinical Research Services (CRS) Revenue (US$ Million) & (2019-2024) 7.1.5 Labcorp Recent Developments 7.2 IQVIA 7.2.1 IQVIA Profile 7.2.2 IQVIA Main Business 7.2.3 IQVIA Clinical Research Services (CRS) Products, Services and Solutions 7.2.4 IQVIA Clinical Research Services (CRS) Revenue (US$ Million) & (2019-2024) 7.2.5 IQVIA Recent Developments 7.3 Syneos Health 7.3.1 Syneos Health Profile 7.3.2 Syneos Health Main Business 7.3.3 Syneos Health Clinical Research Services (CRS) Products, Services and Solutions 7.3.4 Syneos Health Clinical Research Services (CRS) Revenue (US$ Million) & (2019-2024) 7.3.5 Parexel Recent Developments 7.4 Parexel 7.4.1 Parexel Profile 7.4.2 Parexel Main Business 7.4.3 Parexel Clinical Research Services (CRS) Products, Services and Solutions 7.4.4 Parexel Clinical Research Services (CRS) Revenue (US$ Million) & (2019-2024) 7.4.5 Parexel Recent Developments 7.5 PRA 7.5.1 PRA Profile 7.5.2 PRA Main Business 7.5.3 PRA Clinical Research Services (CRS) Products, Services and Solutions 7.5.4 PRA Clinical Research Services (CRS) Revenue (US$ Million) & (2019-2024) 7.5.5 PRA Recent Developments 7.6 PPD 7.6.1 PPD Profile 7.6.2 PPD Main Business 7.6.3 PPD Clinical Research Services (CRS) Products, Services and Solutions 7.6.4 PPD Clinical Research Services (CRS) Revenue (US$ Million) & (2019-2024) 7.6.5 PPD Recent Developments 7.7 CRL 7.7.1 CRL Profile 7.7.2 CRL Main Business 7.7.3 CRL Clinical Research Services (CRS) Products, Services and Solutions 7.7.4 CRL Clinical Research Services (CRS) Revenue (US$ Million) & (2019-2024) 7.7.5 CRL Recent Developments 7.8 ICON 7.8.1 ICON Profile 7.8.2 ICON Main Business 7.8.3 ICON Clinical Research Services (CRS) Products, Services and Solutions 7.8.4 ICON Clinical Research Services (CRS) Revenue (US$ Million) & (2019-2024) 7.8.5 ICON Recent Developments 8 Industry Chain Analysis 8.1 Clinical Research Services (CRS) Industrial Chain 8.2 Clinical Research Services (CRS) Upstream Analysis 8.2.1 Key Raw Materials 8.2.2 Raw Materials Key Suppliers 8.2.3 Manufacturing Cost Structure 8.3 Midstream Analysis 8.4 Downstream Analysis (Customers Analysis) 8.5 Sales Model and Sales Channels 8.5.1 Clinical Research Services (CRS) Sales Model 8.5.2 Sales Channel 8.5.3 Clinical Research Services (CRS) Distributors 9 Research Findings and Conclusion 10 Appendix 10.1 Research Methodology 10.1.1 Methodology/Research Approach 10.1.2 Data Source 10.2 Author Details 10.3 Disclaimer
ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。本レポートと同分野(医療)の最新刊レポート
QYResearch社の医療分野での最新刊レポート
本レポートと同じKEY WORD()の最新刊レポート
よくあるご質問QYResearch社はどのような調査会社ですか?QYリサーチ(QYResearch)は幅広い市場を対象に調査・レポート出版を行う、中国に本社をおく調査会社です。 QYResearchでは年間数百タイトルの調査レポートを出版しています。... もっと見る 調査レポートの納品までの日数はどの程度ですか?在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
注文の手続きはどのようになっていますか?1)お客様からの御問い合わせをいただきます。
お支払方法の方法はどのようになっていますか?納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
データリソース社はどのような会社ですか?当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
|